Inspire Investing LLC purchased a new position in Teleflex Incorporated (NYSE:TFX – Get Rating) in the 1st quarter, Holdings Channel.com reports. The institutional investor purchased 1,038 shares of the medical technology company’s stock, valued at approximately $368,000.
Several other hedge funds and other institutional investors have also added to or reduced their stakes in TFX. City State Bank bought a new position in Teleflex in the fourth quarter worth approximately $27,000. Allworth Financial LP raised its position in shares of Teleflex by 144.4% in the 4th quarter. Allworth Financial LP now owns 110 shares of the medical technology company’s stock worth $36,000 after acquiring an additional 65 shares in the last quarter. Harel Insurance Investments & Financial Services Ltd. lifted its stake in shares of Teleflex by 62.9% during the 4th quarter. Harel Insurance Investments & Financial Services Ltd. now owns 114 shares of the medical technology company’s stock worth $38,000 after purchasing an additional 44 shares during the last quarter. Aquire Wealth Advisors LLC bought a new stake in Teleflex during the fourth quarter valued at about $38,000. Finally, Spire Wealth Management grew its stake in Teleflex by 3,900.0% in the fourth quarter. Spire Wealth Management now owns 120 shares of the medical technology company’s stock valued at $40,000 after purchasing an additional 117 during the last quarter. Hedge funds and other institutional investors own 92.21% of the company’s stock.
A number of research analysts have recently issued reports on the stock. StockNews.com raised shares of Teleflex from a “hold” rating to a “buy” rating in a research report on Thursday, June 2nd. Bank of America assumed coverage on shares of Teleflex in a report on Monday, May 9th. They issued a “neutral” rating and a $315.00 price target on the stock. Trust Financial decreased their price objective on Teleflex from $340.00 to $317.00 and set a “hold” rating for the company in a report on Monday, May 23rd. Royal Bank of Canada reduced their target price on Teleflex from $390.00 to $380.00 in a research report on Monday, May 23rd. Finally, TheStreet downgraded Teleflex from a “b-” rating to a “c+” rating in a report on Monday, May 16th. Five equities research analysts have rated the stock with a hold rating and eight have issued a buy rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $384.92.
In other Teleflex news, Director Stuart A. Randle sold 3,014 shares of the stock in a transaction dated Tuesday, June 7th. The stock was sold at an average price of $283.31, for a total transaction of $853,896.34. Following the sale, the director now directly owns 4,320 shares of the company’s stock, valued at approximately $1,223,899.20. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 1.28% of the stock is currently owned by corporate insiders.
Shares of NYSE:TFX opened at $255.09 on Tuesday. The business has a 50-day moving average price of $273.83 and a 200-day moving average price of $310.76. The stock has a market cap of $11.96 billion, a price-to-earnings ratio of 24.79, a PEG ratio of 1.70 and a beta of 1.17. Teleflex Incorporated has a 52-week low of $244.81 and a 52-week high of $428.36. The company has a quick ratio of 1.53, a current ratio of 2.28 and a debt-to-equity ratio of 0.46.
Teleflex (NYSE:TFX – Get Rating) last posted its quarterly earnings results on Thursday, April 28th. The medical technology company reported $2.88 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.73 by $0.15. The company had revenue of $641.70 million during the quarter, compared to analyst estimates of $631.89 million. Teleflex had a net margin of 17.31% and a return on equity of 17.24%. Teleflex’s revenue for the quarter was up 1.2% compared to the same quarter last year. During the same period last year, the firm posted $2.87 EPS. As a group, equities analysts anticipate that Teleflex Incorporated will post 13.97 EPS for the current fiscal year.
The firm also recently declared a quarterly dividend, which was paid on Wednesday, June 15th. Shareholders of record on Monday, May 16th were issued a $0.34 dividend. This represents a $1.36 annualized dividend and a yield of 0.53%. The ex-dividend date of this dividend was Friday, May 13th. Teleflex’s payout ratio is 13.22%.
About Teleflex (Get Rating)
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.
Want to see what other hedge funds are holding TFX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teleflex Incorporated (NYSE:TFX – Get Rating).
Receive News & Ratings for Teleflex Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Teleflex and related companies with MarketBeat.com’s FREE daily email newsletter.